FDA Is Right on Regulating Cells
August 19, 2012 - (WSJ) -"Scott Gottlieb and Coleen Klasmeier argue that FDA oversight will blunt progress in the promising field of regenerative medicine ("The FDA Wants to Regulate Your Cells," op-ed, Aug. 8). We disagree. An absence of regulation, as with any area of new medical breakthroughs, will almost certainly result in disappointment and potentially put at risk those patients exposed to unproven treatments." Read Full Letter
